Publication

Publication 2009
  1. Morinaga Y, Yanagihara K, Miyashita N, Yamamoto K, Izumikawa K, Seki M, Kakeya H, Yamamoto Y, Mukae H, Yamada Y, Kohno S, Kamihira S. Azithromycin, clarithromycin and telithromycin inhibit MUC5AC induction by Chlamydophila pneumoniae in airway epithelial cells. Pulmonary Pharmacology and Therapeutics 22: 580-6, 2009
  2. Nakamura S, Yanagihara K, Izumikawa K, Seki M, Kakeya H, Yamamoto Y, Senjyu H, Saito A, Kohno S. The Clinical Efficacy of Fluoroquinolone and Macrolide Combination therapy compared with single agent therapy against community-acquired pneumonia caused by Legionella pneumophila. Journal of Infection 59: 222-4, 2009
  3. Yanagihara K, Kihara R, Araki N, Morinaga Y, Seki M, Izumikawa K, Kakeya H, Yamamoto Y, Yamada Y, Kamihira S, Tsukamoto K, Kohno S Efficacy of linezolid against PVL-positive MRSA in a mouse model of hematogenous pulmonary infection Int J Antimicrob Agents 34: 477-81, 2009
  4. Nakamura S, Yanagihara K, Araki N, Morinaga Y, Izumikawa K, Seki M, Kakeya H, Yamamoto Y, Kamihira S, Kohno S. In vivo efficacy of sitafloxacin in a new murine model of nontypable Haemophilus influenzae pneumonia by sterile intratracheal tube. Int J Antimicrob Agents 24: 210-4, 2009
  5. Nakamura S, Yanagihara K, Morinaga Y, Izumikawa K, Seki M, Kakeya H, Yamamoto Y, Kamihira S, Kohno S. Multiplex real-time PCR for rapid detection of beta-lactamase-negative, ampicillin-resistant Haemophilus influenzae (BLNAR) Diagn Microbiol Infect Dis. 64: 72-77, 2009
  6. Nakamura S, Yanagihara K, Morinaga Y, Izumikawa K, Seki M, Kakeya H, Yamamoto Y, Kamihira S, Kohno S. Melting curve analysis for rapid detection of topoisomerase gene mutations in Haemophilus influenza  J. Clin. Microbiol 47: 781-4, 2009
  7. Nakamura S, Yanagihara K, Morinaga Y, Izumikawa K, Seki M, Kakeya H, Yamamoto Y, Kamihira S, Kohno S. Comparative mutant prevention concentration and mutant selection window of sitafloxacin versus other quinolones using strains of H. influenzae with decreasing susceptibility to levofloxacin Int J Antimicrob Agents 33: 489-90, 2009(IF: 3.067)
  8. Izumikawa K, Akamatsu S, Kageyama A, Okada K, Kazuyama Y, Takayanagi N, Nakamura S, Inoue Y, Higashiyama Y, Fukushima K, Ishida T, Sawai T, Yoshimura K, Nakahama C, Ohmichi M, Kakugawa T, Nishioka Y, Aoki N, Seki M, Kakeya H, Yamamoto Y, Yanagihara K, Kohno S. Evaluation of a rapid immunochromatographic ODK0501 assay for detecting Streptococcus pneumoniae antigen in sputum samples from patients with lower respiratory tract infection. Clin Vaccine Immunol 16: 672-678, 2009
  9. Izumikawa K, Tomiyama Y, Ishimoto H, Sakamoto N, Imamura Y, Seki M, Sawai T, Kakeya H, Yamamoto Y, Yanagihara K, Mukae H, Yoshimura K, Kohno S. Unique mutations of the cystic fibrosis transmembrane conductance regulator gene of three cases of cystic fibrosis in Nagasaki, Japan. Intern Med 48: 1327-1331, 2009
  10. Takazono T, Izumikawa K, Mihara T, Kosai K, Saijo T, Imamura Y, Miyazaki T, Seki M, Kakeya H, Yamamoto Y, Yanagihara K, Kohno S. Efficacy of combination antifungal therapy with intraperitoneally administered micafungin and aerosolized liposomal amphotericin B against murine invasive pulmonary aspergillosis. Antimicrob Agents Chemother 53: 3508-3510, 2009
  11. Takazono T, Izumikawa K, Tsurutani J, Tanaka A, Kakugawa T, Fukuda Y, Saito M, Kurihara S, Imamura Y, Seki M, Kakeya H, Yamamoto Y, Yanagihara K, Kohno S. Lemierre's syndrome followed by acute respiratory distress syndrome successfully rescued by antibiotics and hemoperfusion with polymyxin B-immobilized fiber. Jpn J Infect Dis 62: 133-136, 2009
  12. Yanagihara K, Izumikawa K, Higa F, Tateyama M, Tokimatsu I, Hiramatsu K, Fujita J, Kadota J, Kohno S. Efficacy of azithromycin in the treatment of community-acquired pneumonia, including patients with macrolide-resistant Streptococcus pneumoniae infection. Intern Med 48: 527-535, 2009
  13. Nakamura S, Izumikawa K, Seki M, Kakeya H, Yamamoto Y, Yanagihara K, Miyazaki Y, Kohno S. Pulmonary cryptococcosis in late pregnancy and review of published literature. Mycopathologia 167: 125-131, 2009
  14. Saijo T, Miyazaki T, Izumikawa K, Mihara T, Takazono T, Kosai K, Imamura Y, Seki M, Kakeya H, Yamamoto Y, Yanagihara K, Kohno S. Skn7p Is Involved in Oxidative Stress Response and Virulence of Candida glabrata. Mycopathologia. 2009 Aug 20. [Epub ahead of print]
  15. Seki M, Kosai K, Hara A, Imamura Y, Nakamura S, Kurihara S, Izumikawa K, Kakeya H, Yamamoto Y, Yanagihara K, Miyazaki Y, Mukae H, Tashiro T, Kohno S. Expression and analysis of Platelet activating factor (PAF) related molecule in severe pneumonia in mice due to influenza virus and bacterial co-infection using by DNA microarray Jpn J Infect Dis. 62: 6-10, 2009
  16. Seki M, Higashiyama Y, Imamura Y, Nakamura S, Kurihara S, Izumikawa K, Kakeya H, Yamamoto Y, Yanagihara K, Tashiro T, Kohno S. A clinical comparative study of piperacillin and sulbactam/ampicillin in patients with community-acquired bacterial pneumonia. Intern Med. 48: 49-55, 2009
  17. Yamamoto K, Yanagihara K, Sugahara K, Imamura Y, Seki M, Izumikawa K, Kakeya H, Yamamoto Y, Hirakata Y, Kamihira S, Kohno S. In vitro activity of garenoxacin against Streptococcus pneumoniae mutants with characterized resistance mechanisms. Antimicrob Agents Chemother. 53: 3572-3575, 2009.
  18. Osaka A, Yanagihara K, Yasuaki Y, Hasegawa H, Inokuchi N, Hayashi T, Komoda M, Nakamura S, Aoyama M, Sawada T, Kamihira S. Serum KL-6 glycoprotein or surfactant protein-D is elevated in adult T-cell leukemia with distinct pulmonary complications. Tohoku J Exp Med 218: 99-105, 2009

(Presentations)

  1. ISHAM 2009 Izumikawa K. Shigeru Kohno: Fungal infections in non-neutropenic patients chronic pulmonary aspergillosis
  2. ISHAM 2009 Takazono T, Izumikawa K, Mihara T, Kosai K, Saijo T, Imamura Y, Seki M, Kakeya H, Yamamoto Y, Yanagihara K, Kohno S: Efficacy of combination antifungal therapy of micafungin and aerosolized liposomal amphotericin B in murine invasive pulmonary aspergillosis model
  3. 
ISHAM 2009 Saijo T, Izumikawa K, Takazono T, Mihara T, Kosai K, Yamamoto K, Imamura Y, Miyazaki T, Seki M, Kakeya H, Yamamoto Y, Yanagihara K, Kohno S: Skn7p is required for oxidative stress response and virulence in Candida glabrata
  4. 47th Annual meeting of Infectious Diseases Society of America Seki M, Tanaka A, Kosai K, Hara A, Kurihara S, Imamura Y, Izumikawa K, Kakeya H, Yamamoto Y, Yanagihara K, Tashiro T, Kohno S. Platelet activating factor(PAF)related molecule in severe pneumonia in mice due to influenza virus and bacterial co-infection
  5. 109th ASM General Meeting . Morinaga Y, Yanagihara K, Araki N, Yamada K, Nakamura S, Izumikawa K, Seki M, Kakeya H, Yamamoto Y, Yamada Y, Kohno S. Legionella pneumophila Induces MUC5AC via ERK-NFkB Pathway in NCI-H292 Cells.
  6. 49th Interscience Conference on Antimicrobial Agents and Chemotherapy Nakamura S, Yanagihara K, Araki N, Yamada K, Morinaga Y, Izumikawa K, Seki Masafumi, Kakeya H, Yamamoto, Kamihira S and Kohno S : High dose tobramycin inhibits lipopolysaccharide-induced MUC5AC production in human lung epithelial cells